China approves 16 locally-made COVID-19 vaccines for clinical trials
Filed in Shanghai Travel News on February 21, 2021 with no comments
URALLNEWS 0 Comments China has accepted clinical trials for 16 indigenous COVID-19 vaccines, of which six are within the third stage, in keeping with a state-run media report. The newest vaccines for clinical trials are primarily based on recombinant protein, adenovirus vector, nucleic acid and attenuated influenza-viruses applied sciences, state-run Xinhua information company reported on Saturday, citing knowledge from the National Medical Products Administration.…
This data comes from the ChinaPulse.com media intelligence and smart news insights platform.